News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
DeSilva Nishan M
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/04/2023 |
4
| DeSilva Nishan M (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 75,000 options to buy
@ $1.13, valued at
$84.8k
|
|
| 01/05/2022 |
4
| DeSilva Nishan M (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 40,000 options to buy
@ $3.31, valued at
$132.4k
|
|
| 12/06/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
4
| DeSilva Nishan M (Director) has filed a Form 4 on SELECTA BIOSCIENCES INC|
Txns:
| Granted 80,000 options to buy
@ $4.57, valued at
$365.6k
|
|
| 07/09/2021 |
3
| DeSilva Nishan M (Director) has filed a Form 3 on SELECTA BIOSCIENCES INC |
| 05/14/2015 |
4
| DeSilva Nishan M (VP, Finance & Strategy and CFO) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Sold 14,214 shares
@ $84.44, valued at
$1.2M
Sold 9,306 shares
@ $84.91, valued at
$790.2k
Sold 12,148 shares
@ $83.23, valued at
$1M
Sold 11,757 shares
@ $83.32, valued at
$979.6k
Sold 20,938 shares
@ $83.84, valued at
$1.8M
Exercised 14,214 options to buy
@ $14.47, valued at
$205.7k
Exercised 11,757 options to buy
@ $14.47, valued at
$170.1k
Exercised 9,306 options to buy
@ $21.92, valued at
$204k
Exercised 12,148 options to buy
@ $21.92, valued at
$266.3k
Sold 14,214 shares
@ $84.44, valued at
$1.2M
Sold 9,306 shares
@ $84.91, valued at
$790.2k
|
|
| 02/11/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/14/2014 |
4
| DeSilva Nishan M (VP, Corporate Development) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Granted 3,000 shares
@ $0
Granted 35,000 options to buy
@ $74.42, valued at
$2.6M
Granted 5,000 options to buy
@ $74.42, valued at
$372.1k
|
|
| 07/01/2013 |
4
| DeSilva Nishan M (VP, Corporate Development) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Bought 169 shares
@ $17.36, valued at
$2.9k
|
|
| 02/19/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/03/2013 |
4
| DeSilva Nishan M (VP, Corporate Development) has filed a Form 4 on LIGAND PHARMACEUTICALS INC|
Txns:
| Acquired 490 shares
@ $14.535, valued at
$7.1k
|
|
| 06/23/2011 |
4
| DeSilva Nishan M (Director) has filed a Form 4 on ALLOS THERAPEUTICS INC|
Txns:
| Granted 20,000 options to buy
@ $2.06, valued at
$41.2k
|
|
| 04/05/2011 |
4
| DeSilva Nishan M (Director) has filed a Form 4 on Talon Therapeutics, Inc.|
Txns:
| Granted 35,000 options to buy
@ $0.77, valued at
$27k
|
|
| 09/15/2010 |
3/A
| DeSilva Nishan M (Director) has filed a Form 3/A on ALLOS THERAPEUTICS INC |
| 08/03/2010 |
4
| DeSilva Nishan M (Director) has filed a Form 4 on Hana Biosciences Inc|
Txns:
| Granted 40,000 options to buy
@ $0.17, valued at
$6.8k
|
|
| 06/24/2010 |
3
| DeSilva Nishan M (Director) has filed a Form 3 on ALLOS THERAPEUTICS INC |
| 06/16/2010 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|